MedCity News

Shanghai,China-August 2nd 2025: Medtronic company office building

6 Things to Know About Medtronic’s Cyberattack

Bipartisan Bill Seeks to Strengthen Oversight of Medicare Advantage

Lawmakers introduced the Medicare Advantage Improvement Act of 2026 to tighten prior authorization rules, boost transparency and curb practices that delay care.

By Marissa Plescia

BioPharma, Startups

Immunology-Focused Coultreon Adds $125M for Pills That Pack the Punch of Injectable Biologics

Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology target called SIK3. The Series A financing will support Phase 2 clinical trials in psoriasis and ulcerative colitis.

By Frank Vinluan

MedCity Influencers

Digital Arrows icon as a symbol of file transfer and update. Digital technology background

Executing Biologics Technology Transfer through Integrated Operating Models

As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion.

By Lalit Saxena, Jihyun Lee, Gwangsik Kim and Soomin Yim

Latest Video

Latest News

MedCity Influencers

The Quiet Revolution Comes Full Circle: How CMS ACCESS Validates Safety-Net Innovation

While other areas of healthcare have been star-struck by sophisticated AI and massive infrastructure investments, safety net entities have found that the answer is much simpler. Better managing chronic conditions across populations simply requires the right connection at the right time.

By Jomo Kenneth Starke

Opinion

‘Prior Authorization’ Has Become a Dirty Word in Healthcare, But it Might Be Medicare’s Smartest Path Forward

Since its inception, AI in prior auth has only been at work in the commercial healthcare marketplace. Now new innovative approaches that reframe prior auth as a resource instead of a roadblock have come to Medicare via the WISeR model.

By Jeremy Friese

Health Tech

Startup Helping Providers Manage Denied Claims Raises $16M

Amperos Health's Series A round was led by Bessemer Venture Partners, with participation from Uncork Capital and Neo.

By Marissa Plescia

BioPharma, Startups

VC Firm Kurma Partners Closes €215M Fund in Pursuit of ‘Disruptive Therapeutic Solutions’

Kurma Partners’ new fund is the venture capital firm’s fourth and largest. Previous Kurma investments have led to exits that include the acquisitions of Corlieve Therapeutics, Emergence Therapeutics, and Amolyt Pharma.

By Frank Vinluan

Health Tech, Startups, Devices & Diagnostics, Providers

Semaglutide weight loss drug, conceptual illustration. Marketed as Ozempic, semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is used to treat diabetes and for weight management. It increases the production of insulin, the hormone that lowers blood sugar levels, while also suppressing secretion of glucagon, the hormone that raises blood sugar levels. It also reduces hunger and slows gastric emptying

Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy

Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body.

By Katie Adams

The Power Behind Enterprise EHR Software for Large Healthcare Systems

Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.

By Malvika Tarnekar, Director of Product Strategy, PrognoCIS by Bizmatics Inc

MedCity Influencers

The Cancer Crisis We Can See Coming And Have the Tools to Change

Colon cancer has long been considered a disease that comes with old age. However, the trend line of disease has been moving in the wrong direction for years, in a population we long assumed wasn’t at risk. And while researchers continue to investigate the why, there's a parallel conversation we aren't having nearly enough. One that has nothing to do with science, and everything to do with operations.

By Jaimal Soni

MedCity Influencers

Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care

As radiopharmaceuticals continue to evolve, the convergence of scientific innovation, operational practicality, and clinical expertise is opening new possibilities in oncology.

By Robert Den

Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]

How to turn analytics into actual policy outcomes.

By Sellers Dorsey and MedCity News

MedCity Influencers

A mechanical hand with dots hovering over it and a pill showing AI and medicine

The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience

Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data.

By Chip Parkinson

Artificial Intelligence, Startups, Health Tech

Top Silicon Valley VCs Are Backing a New Health Tech Residency Program

The AI Health Fund launched Treehub, a new residency program designed to back and build healthcare AI startups at the earliest stages, often before companies are even formed. It is supported by prominent figures in the Silicon Valley venture capital world, including Tim Draper and Anne Wojcicki.

By Katie Adams

BioPharma, Pharma

Regeneron Gets Landmark FDA Approval for First Gene Therapy for Hearing Loss

Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars.

By Frank Vinluan

Payers

SCAN CEO Urges Brokers to Drop Plans That Treat Them Poorly — One Says She Has No Choice

SCAN Health Plan CEO Sachin Jain urged brokers to abandon for-profit plans that treat them poorly, but one broker argued they often can’t because dominant players like UnitedHealth Group control so much of the healthcare system.

By Marissa Plescia

MedCity Influencers

Why Quality Shareback is the Missing Fuel for the Healthcare Interoperability Engine

The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable.

By Patrick Lane

MedCity Influencers

The Healthcare Industry Has a Last Mile Problem — It Hasn’t Realized It Yet

Healthcare has solved for the hard part. The science, the surgery, the diagnosis: by global standards, we're exceptional. What we haven't solved for is what happens when the patient goes home.

By Jenny Lee

Policy, Payers

How the DOJ Is Tackling Fraud in the ACA Marketplace

At the Medicarians Conference, Ricardo Carcas, assistant special agent in charge of the Office of Investigations, discussed cases of fraud in the ACA and how the DOJ is combatting it.

By Marissa Plescia